US FDA News: FDA In Brief: FDA Announces Public Workshop to Reconsider Mandatory Prescriber Education for Opioids

The FDA announces a two-day public workshop to give stakeholders an opportunity to provide input on aspects of the current opioid crisis that could be mitigated in a measurable way by requiring mandatory prescriber education as part of a REMS.
Read more: FDA In Brief: FDA Announces Public Workshop to Reconsider Mandatory Prescriber Education for Opioids